NewsRx

Search our medical news database

HIV Vaccines

Phase III Trials Underway in Several Countries

Published in TB and Outbreaks Week, July 4th, 2000

Phase III trials of multivalent gp120 HIV vaccines are underway in several countries.

"Virus variation is one of the greatest challenges in HIV-1 vaccine development," observed P. Berman and colleagues from VaxGen, Inc., California, Denver Public Health, Colorado, and Thailand. "We have employed this approach to develop two vaccines designed to be effective against the majority of viruses circulating in North America, Western Europe, and Thailand."

Berman et al. presented data from their study at the Keystone Symposium, "Novel Biological Approaches to HIV-1 Infection Based on New Insights into HIV Biology," held in Keystone, Colorado. The title of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook